As a result, several studies have proposed routine inclusion of IHC for BAP1 when investigating uveal melanoma and malignant mesothelioma (Koopmans et al., 2014, Cigognetti et al., 2015, Andrici et al., 2016). Here, BAP1 is linked to malignant mesothelioma.